Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Immunol ; 166(5): 3533-41, 2001 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-11207313

RESUMO

Whether or not NO plays a critical role in murine CMV (MCMV) infection has yet to be elucidated. In this study, we examined the role of NO in acute infection with MCMV using NO synthase type 2 (NOS2)-deficient mice. NOS2(-/-) mice were more susceptible to lethal infection with MCMV than NOS2(+/+) mice and generated a much higher peak virus titer in the salivary gland after acute infection. A moderate increase in the MCMV titer was also observed in other organs of NOS2(-/-) mice such as the spleen, lung, and liver. The immune responses to MCMV infection including NK cell cytotoxicity and CTL response in NOS2(-/-) mice were comparable with those of NOS2(+/+) mice. Moreover, the ability to produce IFN-gamma is not impaired in NOS2(-/-) mice after MCMV infection. The peritoneal macrophages from NOS2(-/-) mice, however, exhibited a lower antiviral activity than those from NOS2(+/+) mice, resulting in an enhanced viral replication in macrophages themselves. Treatment of these cells from NOS2(+/+) mice with a selective NOS2 inhibitor decreased the antiviral activity to a level below that obtained with NOS2(-/-) mice. In addition, the absence of NOS2 and NOS2-mediated antiviral activity of macrophages resulted in not only an enhanced MCMV replication and a high mortality but also a consequent risk of the latency. It was thus concluded that the NOS2-mediated antiviral activity of macrophages via NO plays a protective role against MCMV infection at an early and late stage of the infection.


Assuntos
Infecções por Herpesviridae/enzimologia , Infecções por Herpesviridae/imunologia , Muromegalovirus/imunologia , Óxido Nítrico Sintase/fisiologia , Doença Aguda , Animais , Citotoxicidade Imunológica/genética , Infecções por Herpesviridae/genética , Infecções por Herpesviridae/mortalidade , Interferon gama/biossíntese , Células Matadoras Naturais/enzimologia , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/virologia , Macrófagos Peritoneais/enzimologia , Macrófagos Peritoneais/imunologia , Macrófagos Peritoneais/virologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Muromegalovirus/crescimento & desenvolvimento , Óxido Nítrico Sintase/deficiência , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , Taxa de Sobrevida , Linfócitos T Citotóxicos/enzimologia , Linfócitos T Citotóxicos/imunologia , Linfócitos T Citotóxicos/virologia , Carga Viral , Ensaio de Placa Viral , Latência Viral/imunologia , Replicação Viral/imunologia
2.
Br J Pharmacol ; 132(4): 797-8, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11181419

RESUMO

Botulinum neurotoxin type A (BoNT/A, 1.5 nM) completely inhibited indirectly evoked twitches in in vitro mouse phrenic nerve-diaphragm preparations within 40 - 45 min. Black tea extract, thearubigin fraction (TRB), mixed with BoNT/A blocked the inhibitory effect of the toxin. The protective effect of TRB extended to botulinum neurotoxins types B and E (BoNT/B and BoNT/E) and tetanus toxin, but not to tetrodotoxin. TRB was also effective against oral toxicity of BoNT/A, B and E. Thus, TRB may be of potential benefit in protecting the paralytic actions of botulinum neurotoxins (BoNTs), but its use is limited by mixing with the toxin.


Assuntos
Toxinas Botulínicas Tipo A/toxicidade , Catequina/análogos & derivados , Catequina/farmacologia , Fenóis/farmacologia , Chá , Animais , Feminino , Técnicas In Vitro , Masculino , Camundongos , Junção Neuromuscular/efeitos dos fármacos , Junção Neuromuscular/fisiologia , Extratos Vegetais/farmacologia , Polifenóis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...